![Robert Browne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Browne
Financieel Directeur/CFO bij Viron Therapeutics, Inc.
Profiel
Robert Browne is currently the Chief Financial Officer at Viron Therapeutics, Inc. He previously held the same position at Telesta Therapeutics, Inc. and Fennec Pharmaceuticals, Inc. Additionally, he was a Member of The Canadian Institute of Chartered Accountants.
Actieve functies van Robert Browne
Bedrijven | Functie | Begin |
---|---|---|
Viron Therapeutics, Inc.
![]() Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Robert Browne
Bedrijven | Functie | Einde |
---|---|---|
TELESTA THERAPEUTICS INC | Financieel Directeur/CFO | - |
FENNEC PHARMACEUTICALS INC. | Financieel Directeur/CFO | - |
The Canadian Institute of Chartered Accountants
![]() The Canadian Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FENNEC PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Viron Therapeutics, Inc.
![]() Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
The Canadian Institute of Chartered Accountants
![]() The Canadian Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada. | Commercial Services |
Telesta Therapeutics, Inc.
![]() Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |